Offer - Urjas Oil for just ₹ 1 X
Glyciphage P 7.5 Tablet is a prescription medicine that is available as a Tablet. Glyciphage P 7.5 Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Glyciphage P 7.5 Tablet. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Glyciphage P 7.5 Tablet include Stomach Upset, Difficulty urinating, Muscle Ache. Some other side effects of Glyciphage P 7.5 Tablet have been listed ahead. Usually, these side effects of Glyciphage P 7.5 Tablet go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Glyciphage P 7.5 Tablet has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Warnings related to Glyciphage P 7.5 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Glyciphage P 7.5 Tablet is contraindicated in people with pre-existing medical conditions like Congestive Heart Failure (CHF), Anemia, Shock as it can result in adverse effects. Other contraindications of Glyciphage P 7.5 Tablet have been discussed in the sections ahead.
Drug interactions for Glyciphage P 7.5 Tablet have been reported in the medical literature. Refer to the list below for further details.
In addition to these precautions, you may also note that Glyciphage P 7.5 Tablet is safe while driving, and is is addictive in nature.
Glyciphage P 7.5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Glyciphage P 7.5 Tablet safe for pregnant women?
Glyciphage P can have harmful effects in pregnant women. If you experience any discomfort after using Glyciphage P, then discontinue the use and take your doctor's advice.
Is the use of Glyciphage P 7.5 Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Glyciphage P. If you see any side effects, stop taking Glyciphage P immediately and talk to your doctor. Take Glyciphage P again, only after your doctor's advice.
What is the effect of Glyciphage P 7.5 Tablet on the Kidneys?
Glyciphage P has very mild side effects on the kidneys.
What is the effect of Glyciphage P 7.5 Tablet on the Liver?
You may experience side effects on your liver after taking Glyciphage P. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Glyciphage P 7.5 Tablet on the Heart?
Glyciphage P may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
If you are suffering from any of the following diseases, you should not take Glyciphage P 7.5 Tablet unless your doctor advises you to do so -
Is this Glyciphage P 7.5 Tablet habit forming or addictive?
Forming a habit of Glyciphage P 7.5 Tablet has not been reported.
Interaction between Food and Glyciphage P 7.5 Tablet
There is no information on the effects of taking Glyciphage P 7.5 Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Glyciphage P 7.5 Tablet
Chances of side effects of drinking alcohol while taking Glyciphage P 7.5 Tablet are low. If you feel any adverse effects, please seek medical advice as soon as possible.
Yes, Glyciphage P commonly cause stomach upset like diarrhea, abdominal pain, nausea, and vomiting. To avoid these side effects you should take Glyciphage P with your meal and increase the dose gradually.
Glyciphage P helps in weight loss by reducing appetite and food intake. It also increases the insulin sensitivity in your body to work more effectively. This lead to decreased glucose production increases the use of glucose and decrease the fat deposition further helps in weight loss. However, Glyciphage P is not approved for weight loss, this is an off-label use.
Yes, you can take Glyciphage P with a beta-blocker. People with diabetes tend to develop heart disease or stroke at an earlier age than the general population. One reason for this is that high glucose levels increase your risk of high blood pressure (hypertension). No harmful interactions are seen between them. However, a recent study suggests that beta-blockers can decrease the plasma level of Glyciphage P and long-term use can increase lactic acid and uric acid in the blood.
Lactic acidosis associated with Glyciphage P treatment is a rare but fatal adverse effect. Lactic acidosis appears to result from biguanide interference causing an increase in production and decrease in clearance of lactate leading to higher cellular lactate levels. A decrease in pyruvate carboxylase activity, the rate-limiting enzyme in the formation of glucose from lactate, can also decrease hepatic metabolism of lactate. leading to increasing lactic acidosis. Signs and symptoms of Glyciphage P induced lactic acidosis are nonspecific and include anorexia, nausea, vomiting, altered level of consciousness, hyperpnoea, abdominal pain, and thirst.
Glyciphage P is used with a proper diet and exercise program, to treat diabetes. It is also used with other medication to reduce the high blood sugar. It is used in a patient with type2 diabetes. It is also used in the treatment of polycystic ovarian syndrome (PCOS) and cancer.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033